Press release
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market
Bacteriophages have been shown to be a powerful alternative to antibiotics, which are losing efficacy due to rapid growth and spread of resistance-forming genes. Topically, phage therapy has been utilized to treat secondary infected burn-mediated ulcers, infected diabetic foot ulcers, and other unexplained persistently infected wounds. Recent breakthroughs in phage genetic engineering enable the intentional modification of wild phage isolates to make them more suitable for therapeutic reasons by changing host specificity and/or increasing other traits on demand. Phage synthesis processes have evolved dramatically in the previous five years.
The latest research report serves as a perfect example of the precise analysis of the global Bacteriophage Market. It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Bacteriophage industry.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2245
Drivers of the Bacteriophage Market :
Several factors are driving the growth of the Bacteriophage Market. Notably, the escalating prevalence of antimicrobial-resistant infections, coupled with the diminishing effectiveness of antibiotics, is driving demand for alternative treatment options such as phage therapy. Additionally, advancements in biotechnology and genomics are enabling the identification, characterization, and engineering of phages for targeted and personalized therapies. Moreover, the growing awareness of phage therapy's potential benefits, including its specificity, low toxicity, and potential to overcome antibiotic resistance, is driving interest and investment in phage-based treatments.
Restraints and Challenges
Despite its promising growth prospects, the Bacteriophage Market faces certain restraints. One significant challenge is the limited understanding of phage biology, pharmacokinetics, and safety profiles compared to traditional antibiotics. The complex interactions between phages and bacteria, as well as potential immunological responses in patients, pose challenges for clinical development and regulatory approval of phage-based therapies. Additionally, the lack of standardized manufacturing processes and regulatory pathways for phage products may hinder market growth and adoption. Overcoming these challenges while addressing safety and regulatory concerns remains crucial for the widespread acceptance and commercialization of phage therapy.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2245
The report also discusses the key players involved in the market such as:
ADM, Armata Pharmaceuticals, Inc., Proteon Pharmaceuticals, BiomX, Adaptive Phage Therapeutics, Biochimpharm JSC., CYTOPHAGE TECHNOLOGIES INC., ACD Pharma, ELIGO BIOSCIENCE., and Intralytix, Inc.
The report provides a thorough estimation of the overall impact of the pandemic on the Bacteriophage Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Bacteriophage Market
Bacteriophage Latest Industry News
On 11 July 2023, Armata Pharmaceuticals, Inc., a biotechnology company focused on antibioticresistant and difficult to treat bacterial infections, announced that it has signed into a credit and security arrangement with Innoviva Strategic Opportunities LLC, a wholly owned subsidiary of Innoviva, Inc. Before transactional fees, the gross proceeds of the credit arrangement upon closing are USD 25 million.
On 12 January 2023, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company announced the first patient has been dosed in the PHAGE clinical study, an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. The trial is determining if bacteriophage therapy is safe and capable of reducing the number of bacteria in volunteers' lungs.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2245
Bacteriophage Market Segment Analysis :
Emergen Research has segmented the global bacteriophage market on the basis product type, route of administration, application, distribution channel, and region:
o Product Type Outlook (Revenue, USD Million; 2019-2032)
Phage Probiotics
Phage Therapeutics
o Route of Administration Outlook (Revenue, USD Million; 2019-2032)
Oral
Topical
Others
o Application Outlook (Revenue, USD Million; 2019-2032)
Gastroenterology
Respiratory Infections
Skin Infection
Wound Prophylaxis
Urogenital Infection
Others
o Distribution Channel Outlook (Revenue, USD Million; 2019-2032)
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
· Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/bacteriophage-market
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Custom Intelligence services https://www.emergenresearch.com/custom-intelligence
Growth Consulting Services https://www.emergenresearch.com/growth-consultant
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research here
News-ID: 3491886 • Views: …
More Releases from Emergen research
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and…
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the…
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion…
Cosmetic Active Ingredients Market Size Worth USD 56.15 Billion in 2032 | Emerge …
The global cosmetic active ingredients market size was USD 31.80 Billion in 2022 and is expected to register a revenue CAGR of 5.8% during the forecast period, according to the latest analysis by Emergen Research. The rapid and effective approval of ingredients by reputable authorities, combined with increasing impact of social media advertising, are major factors contributing to the cosmetic active ingredients market revenue growth. According to The Journal…
More Releases for Bacteriophage
Bacteriophage Market to Discern Steadfast Expansion |Forecast - 2031
Global Bacteriophage Market: Snapshot
Rise in the prevalence of different antibiotic-resistant infections across the globe is projected to help the global bacteriophage market expand at a CAGR of 3.7% in the forecast period of 2020 to 2030.
Bacteriophages, or phages, refer to viruses that selectively target and exclusively kill bacteria. These phases are considered one of the most widespread biological entities that have an ability to efficiently fight and kill multi-drug-resistant bacteria.…
Global bacteriophage market
Global bacteriophage market is anticipated to foresee a compound annual growth rate of 8.1% from 2021 to 2028. Bacteriophage also known as Phage or phage therapy are engineered viruses which are further used to infect and destroy bacteria. Bacteriophage can be used as an alternative of antibiotics as they are much more specific and harm only the bacteria, not the host organism. Overuse of antibiotics exceedingly affects the human body…
Bacteriophage Market Growth and Global Industry Status by 2028
Global Bacteriophage Market: Overview
Bacteriophage, also simply known as phages, are bacterial viruses that infect and feed on bacteria to replicate themselves. Historically, researchers observed their role in limiting bacterial activity but study on phages could not make a mark on bacterial genomics. In recent years, there has been resurgence of interest in phages research across the globe for their critical role in bacterial genetics and molecular biology. Being most abundantly…
Impact of Outbreak of COVID-19 on Bacteriophage Therapy Market
The recent report titled “Covid-19 Impact on Global Bacteriophage Therapy Market Size, Status and Forecast 2020-2026” offered by Researchmoz.us, comprises of a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Bacteriophage Therapy market”.
This is the most recent report inclusive of the COVID-19 effects…
Bacteriophage Market | Know the Market Players, Size, Business Opportunies etc.
The global bacteriophage market was valued at US$ 567.9 million in 2017 and increased to CAGR by 3.9 per cent from 2018 to 2026.
Market Insights
Bacteriophages or phages have recently been recognized as an effective tool in modern biotechnology through a multitude of researches promoting the potential use of bacteriophages across a number of applications. Researchers have also proposed bacteriophages as a viable alternative to antibiotics for a number of…
Bacteriophage Market Size, Share, Development by 2024
Market Research Report Store offers a latest published report on Bacteriophage Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Bacteriophage market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 190.4 million by 2024, from US$ 162.9 million in 2019. In particular, this…
